EEG-based Personalized Transcranial Magnetic Stimulation (eTMS) to Treat Post-Traumatic Stress Disorder
Wave Neuroscience · NCT06892028
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 22–65 · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Not applicable
- Target enrollment
- 110
- US sites recruiting
- 2
- Study start
- February 12, 2025
- Record last updated
- March 24, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a randomized, sham controlled study of the Electroencephalogram (EEG) based Transcranial Magnetic Stimulation (eTMS) treatment for Post-Traumatic Stress Disorder (PTSD). The recruitment goal is 110 participants who are United States Military veterans or first responders (e.g., firefighters, police, paramedics, etc.). The Study includes an EEG recording in order to determine the optimal treatment parameters for the eTMS system, followed by 15 in-office visits that take place over 21-28 total days. Two eTMS treatment sessions are administered during each office visit.
Being studied: EEG-based personalized TMS; Sham Comparator
Conditions: Stress Disorder, Post Traumatic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willing and able to consent to participate in the study via signed Informed Consent
- Age 22 - 65 years
- Diagnosis of PTSD according to DSM-5 criteria via the Clinician-Administered PTSD Scale (CAPS).
- Onset of symptoms meeting the DSM-5 criteria for PTSD symptoms persisting for a minimum of 6 months prior to the Screening Visit
- Veterans Administration PCL-5 cut point score of 31 or above
- Positive identification as either a Veteran, or First Responder (e.g., emergency medical service provider, firefighter, or any other emergency response personnel)
Exclusion Criteria
- Uncontrolled medical, psychological or neurological condition
- Pregnant, or female unwilling to use effective birth control during the course of the trial
- Metal objects in the head
- Past exposure to metal fragments, permanent piercings, and/or other possible metal sources in the head and neck
- Current participation in any interventional research protocol
- History of any type of Electroconvulsive Therapy (ECT) or repetitive Transcranial Magnetic Stimulation (rTMS)
- History of stroke or intracranial lesion or increased intracranial pressure
- History of epilepsy of seizure
- Family history of epilepsy or seizure in 1st degree relative
- An elevated risk of suicide or violence to others
Recruiting US locations
Wright State University
Dayton, OH 45435
Site contact: Matt Sherwood, PhD · 937-524-3924 · matt.sherwood@wright.edu
D2 Human Performance Center
Pickerington, OH 45435
Site contact: Erin Woodburn · 937-775-2342 · coordinator@etmsfda.com
Study contacts (from the official record)
- Matthew Sherwood, PhD · 937-775-2342 · msherwood@etmsfda.com
- Walter Mysiw, MD · 614-293-3433 · coordinator@etmsfda.com
Similar studies in Ohio
All mental health studies in Ohio →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Cincinnati, OH + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
Bristol-Myers Squibb
- Location
- North Canton, OH + 18 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With…
LivaNova
- Location
- Columbus, OH + 49 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
Bristol-Myers Squibb
- Location
- Cincinnati, OH + 20 other US sites
- Eligibility basics
- Ages 18–65